| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |